• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何使用超声弹性成像识别非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)成年患者的晚期纤维化——文献综述及多步骤方法建议

How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography-A Review of the Literature and Proposed Multistep Approach.

作者信息

Taru Madalina-Gabriela, Neamti Lidia, Taru Vlad, Procopciuc Lucia Maria, Procopet Bogdan, Lupsor-Platon Monica

机构信息

Hepatology Department, Regional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400162 Cluj-Napoca, Romania.

Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

出版信息

Diagnostics (Basel). 2023 Feb 19;13(4):788. doi: 10.3390/diagnostics13040788.

DOI:10.3390/diagnostics13040788
PMID:36832276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9955630/
Abstract

Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic steatohepatitis (NASH), represent, nowadays, real challenges for the healthcare system. Liver fibrosis is the most important prognostic factor for NAFLD, and advanced fibrosis is associated with higher liver-related mortality rates. Therefore, the key issues in NAFLD are the differentiation of NASH from simple steatosis and identification of advanced hepatic fibrosis. We critically reviewed the ultrasound (US) elastography techniques for the quantitative characterization of fibrosis, steatosis, and inflammation in NAFLD and NASH, with a specific focus on how to differentiate advanced fibrosis in adult patients. Vibration-controlled transient elastography (VCTE) is still the most utilized and validated elastography method for liver fibrosis assessment. The recently developed point shear wave elastography (pSWE) and two-dimensional shear wave elastography (2D-SWE) techniques that use multiparametric approaches could bring essential improvements to diagnosis and risk stratification.

摘要

非酒精性脂肪性肝病(NAFLD)及其进展形式非酒精性脂肪性肝炎(NASH)如今已成为医疗系统面临的实际挑战。肝纤维化是非酒精性脂肪性肝病最重要的预后因素,而晚期纤维化与更高的肝脏相关死亡率相关。因此,非酒精性脂肪性肝病的关键问题在于将非酒精性脂肪性肝炎与单纯性脂肪变性区分开来,并识别晚期肝纤维化。我们严格审查了用于定量表征非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的纤维化、脂肪变性和炎症的超声(US)弹性成像技术,特别关注如何区分成年患者的晚期纤维化。振动控制瞬时弹性成像(VCTE)仍然是用于肝纤维化评估的最常用且经过验证的弹性成像方法。最近开发的使用多参数方法的点剪切波弹性成像(pSWE)和二维剪切波弹性成像(2D-SWE)技术可能会给诊断和风险分层带来实质性改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/c10e08dbffae/diagnostics-13-00788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/fb0f87b96109/diagnostics-13-00788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/e2dd6c4ce970/diagnostics-13-00788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/4c837798bd9a/diagnostics-13-00788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/c10e08dbffae/diagnostics-13-00788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/fb0f87b96109/diagnostics-13-00788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/e2dd6c4ce970/diagnostics-13-00788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/4c837798bd9a/diagnostics-13-00788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/802e/9955630/c10e08dbffae/diagnostics-13-00788-g004.jpg

相似文献

1
How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography-A Review of the Literature and Proposed Multistep Approach.如何使用超声弹性成像识别非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)成年患者的晚期纤维化——文献综述及多步骤方法建议
Diagnostics (Basel). 2023 Feb 19;13(4):788. doi: 10.3390/diagnostics13040788.
2
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.弹性成像和磁共振成像在非酒精性脂肪性肝病患者中的诊断准确性:系统评价和荟萃分析。
J Hepatol. 2021 Oct;75(4):770-785. doi: 10.1016/j.jhep.2021.04.044. Epub 2021 May 13.
3
Advances in ultrasound elastography for nonalcoholic fatty liver disease.超声弹性成像技术在非酒精性脂肪性肝病中的研究进展。
J Med Ultrason (2001). 2020 Oct;47(4):521-533. doi: 10.1007/s10396-020-01040-8. Epub 2020 Aug 3.
4
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography.肝细胞癌与非酒精性脂肪性肝病:超声弹性成像在更好评估方面向前迈进的一步
Cancers (Basel). 2020 Sep 28;12(10):2778. doi: 10.3390/cancers12102778.
5
Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.用于肝脏疾病的超声剪切波弹性成像:对该领域众多参与者的批判性评估
Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12.
6
Liver fibrosis assessment: MR and US elastography.肝脏纤维化评估:磁共振和超声弹性成像。
Abdom Radiol (NY). 2022 Sep;47(9):3037-3050. doi: 10.1007/s00261-021-03269-4. Epub 2021 Oct 23.
7
Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD.多步骤策略中瞬时弹性成像与二维剪切波弹性成像检测非酒精性脂肪性肝病肝纤维化程度的比较
Hepatology. 2021 Jun;73(6):2196-2205. doi: 10.1002/hep.31655. Epub 2021 May 19.
8
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
9
The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.基于肥胖症手术候选者的侵袭性和非侵袭性发现,甲状旁腺激素对非酒精性脂肪性肝病的预测作用。
Eat Weight Disord. 2022 Mar;27(2):693-700. doi: 10.1007/s40519-021-01151-2. Epub 2021 May 17.
10
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.定量多参数磁共振成像有助于日本队列中的非酒精性脂肪性肝炎诊断。
World J Gastroenterol. 2021 Feb 21;27(7):609-623. doi: 10.3748/wjg.v27.i7.609.

引用本文的文献

1
Beyond Weight Loss: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic Steatosis and Stiffness in MASLD.超越体重减轻:替尔泊肽联合低能量生酮饮食与低热量饮食对非酒精性脂肪性肝病(MASLD)患者肝脂肪变性和肝硬度的比较效果
Nutrients. 2025 Jul 24;17(15):2409. doi: 10.3390/nu17152409.
2
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量:方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
3

本文引用的文献

1
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.肝硬度值预测桥接纤维化和肝硬化患者疾病进展和临床结局的价值。
Gut. 2023 Mar;72(3):581-589. doi: 10.1136/gutjnl-2022-327777. Epub 2022 Sep 9.
2
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
3
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice.
Update of machine learning for ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a bright future for deep learning.
用于代谢功能障碍相关脂肪性肝病超声诊断的机器学习进展:深度学习的光明未来。
PeerJ. 2025 Jun 30;13:e19645. doi: 10.7717/peerj.19645. eCollection 2025.
4
Value of a multi-indicator model combining Elast PQ technology, blood lipids, liver function, and uric acid for early diagnosis of alcoholic fatty liver disease.结合Elast PQ技术、血脂、肝功能和尿酸的多指标模型对酒精性脂肪性肝病早期诊断的价值
Am J Transl Res. 2025 Apr 15;17(4):3050-3062. doi: 10.62347/GMGX5873. eCollection 2025.
5
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD.非侵入性检测在评估代谢相关脂肪性肝病(MASLD)中替代肝活检的应用
Medicina (Kaunas). 2025 Apr 16;61(4):736. doi: 10.3390/medicina61040736.
6
Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD).血液透析中的氧化应激与炎症:有无晚期非酒精性脂肪性肝病(NAFLD)患者的比较
Ren Fail. 2025 Dec;47(1):2455523. doi: 10.1080/0886022X.2025.2455523. Epub 2025 Jan 22.
7
FAST and Agile-the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin.快速而敏捷——MASLD 漂移:在符合 MASLD 标准的 246 例活检证实的非酒精性脂肪性肝病患者中验证 Agile 3+、Agile 4 和 FAST 评分在白种人流行起源中的适用性。
PLoS One. 2024 May 23;19(5):e0303971. doi: 10.1371/journal.pone.0303971. eCollection 2024.
8
Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective.非酒精性脂肪性肝病的无创诊断:现状与未来展望。
Heliyon. 2024 Feb 29;10(5):e27325. doi: 10.1016/j.heliyon.2024.e27325. eCollection 2024 Mar 15.
9
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients.超声衰减分析与控制衰减参数在非酒精性脂肪性肝病患者肝脏脂肪变诊断及分级中的对比研究。
BMC Gastroenterol. 2024 Feb 23;24(1):81. doi: 10.1186/s12876-024-03160-8.
10
Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography.通过纳入超声弹性成像的风险分层算法探索加强非酒精性脂肪性肝病(NAFLD)中肝细胞癌筛查和监测的机会。
Cancers (Basel). 2023 Aug 14;15(16):4097. doi: 10.3390/cancers15164097.
关于在常规临床实践中用于评估纤维化的非侵入性检测及相关临界值的真实世界证据。
JHEP Rep. 2022 Sep 22;5(1):100596. doi: 10.1016/j.jhepr.2022.100596. eCollection 2023 Jan.
4
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis.非侵入性检测在临床实践中用于识别非酒精性脂肪性肝炎高危患者的实际应用。
Aliment Pharmacol Ther. 2023 Feb;57(3):304-312. doi: 10.1111/apt.17346. Epub 2022 Dec 13.
5
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.基于 FibroScan 的 Agile 评分增强对非酒精性脂肪性肝病患者肝纤维化和肝硬化的诊断。
J Hepatol. 2023 Feb;78(2):247-259. doi: 10.1016/j.jhep.2022.10.034. Epub 2022 Nov 12.
6
Efficacy of shear wave dispersion imaging for viscoelastic assessment of the liver in acute graft-versus-host disease rats.剪切波频散成像在急性移植物抗宿主病大鼠肝脏粘弹性评估中的效能
Quant Imaging Med Surg. 2022 Nov;12(11):5044-5055. doi: 10.21037/qims-22-374.
7
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.序贯应用 Baveno VII 标准和 VITRO 评分可提高临床显著门静脉高压症的诊断率。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1854-1863.e10. doi: 10.1016/j.cgh.2022.09.032. Epub 2022 Oct 14.
8
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model.非侵入性预测因子在 NASH 肝硬化中的临床显著门脉高压:ANTICIPATE 模型的验证和基于实验室模型的开发。
Hepatol Commun. 2022 Dec;6(12):3324-3334. doi: 10.1002/hep4.2091. Epub 2022 Oct 10.
9
Inter-platform Variability of Liver Elastography: Pairwise Comparisons of Four Devices.跨平台肝脏弹性成像的可变性:四种设备的两两比较。
Ultrasound Med Biol. 2022 Nov;48(11):2258-2266. doi: 10.1016/j.ultrasmedbio.2022.06.018. Epub 2022 Aug 30.
10
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.一种联合 Baveno VII 和脾脏硬度算法,以改善代偿期慢性肝病患者临床显著门静脉高压的无创诊断。
Am J Gastroenterol. 2022 Nov 1;117(11):1825-1833. doi: 10.14309/ajg.0000000000001887. Epub 2022 Jul 21.